Oracle Investment Management Inc Soleno Therapeutics Inc Transaction History

Oracle Investment Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$1.24 - $3.3 $1.91 Million - $5.08 Million	-1,538,384 Reduced 41.91%	2,132,000 $2.69 Million
Q2 2020 Aug 14, 2020	SELL	$1.77 - $4.23 $354,430 - $847,027	-200,243 Reduced 5.17%	3,670,384 $8.15 Million
Q3 2019 Nov 14, 2019	BUY	$1.5 - $2.99 $85,603 - $170,636	57,069 Added 1.5%	3,870,627 $5.81 Million
Q1 2019 May 15, 2019	BUY	$1.35 - $2.68 $175,990 - $349,372	130,363 Added 3.54%	3,813,558 $7.86 Million
Q4 2018 Feb 14, 2019	BUY	$1.55 - $2.3 $1.93 Million - $2.86 Million	1,245,135 Added 51.07%	3,683,195 $6.3 Million
Q2 2018 Aug 14, 2018	BUY	$1.56 - $3.1 $78,000 - $155,000	50,000 Added 2.09%	2,438,060 $5.71 Million
Q4 2017 Feb 14, 2018	BUY	$1.39 - $2.73 $3.32 Million - $6.52 Million	2,388,060	2,388,060 $4.3 Million

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $468M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Oracle Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Oracle Investment Management Inc with notifications on news.